Encompass Health Corporation Stock

$107.13

1.51% yesterday

NYSE, Jul 24, 10:00 pm CET

ISIN

US29261A1007

Symbol

EHC

Reports

Quarter | Annual

Index

NYSE Composite, S&P MidCap 400

Sector

Health Care Equipment & Services

Industry

Health Care Providers & Services

Overview Dividends Analysts Charts News Strategies

Encompass Health Corporation Stock price

$107.13

+54.62 104.03% 5Y

NYSE, Closing price Thu, Jul 24 2025

-1.64 1.51%

ISIN

US29261A1007

Symbol

EHC

Reports

Quarter | Annual

Index

NYSE Composite, S&P MidCap 400

Sector

Health Care Equipment & Services

Industry

Health Care Providers & Services

Key metrics

Basic

Market capitalization

$11.0b

Enterprise Value

$13.3b

Net debt

$2.4b

Cash

$95.8m

Shares outstanding

100.7m

Valuation (TTM | estimate)

P/E

22.5 | 21.5

P/S

2.0 | 1.8

EV/Sales

2.4 | 2.2

EV/FCF

34.5

P/B

5.1

Dividends

DPS

$0.47

Yield 1Y | 5Y

0.4% | 1.1%

Growth 1Y | 5Y

-21.7% | -11.7%

Payout 1Y | 3Y

10.6% | 17.7%

Increased

0 Years

Financials (TTM | estimate)

Revenue

$5.5b | $6.0b

EBITDA

$1.2b | $1.2b

EBIT

$923.4m | $939.1m

Net Income

$492.0m | $509.3m

Free Cash Flow

$386.4m

Growth (TTM | estimate)

Revenue

11.2% | 10.8%

EBITDA

18.3% | 4.5%

EBIT

21.4% | 8.6%

Net Income

31.5% | 12.5%

Free Cash Flow

63.9%

Financial Health

Equity Ratio

31.6%

Return on Equity

21.9%

ROCE

16.0%

ROIC

12.8%

Debt/Equity

1.1

EPS

$4.8

FCF per Share

$3.8

Short interest

1.2%

Employees

25k

Rev per Employee

$210.0k

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Get Started for Free Today

Encompass Health Corporation Stock Analysis

Unlock Scores for Free

??

17 Analysts have issued a Encompass Health Corporation forecast:

16x Buy

94%

More details on Analyst Estimates Including Price Targets

17 Analysts have issued a Encompass Health Corporation forecast:

Buy

94%

Hold

Analyst Estimates with Stock Price Targets

Financial data from Encompass Health Corporation

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	5,513 5,513	11% 11% 100%
- Direct Costs	243 243	9% 9% 4%
Gross Profit	5,270 5,270	11% 11% 96%
- Selling and Administrative Expenses	3,221 3,221	9% 9% 58%
- Research and Development Expense	- -	- -
EBITDA	1,232 1,232	18% 18% 22%
- Depreciation and Amortization	309 309	10% 10% 6%
EBIT (Operating Income) EBIT	923 923	21% 21% 17%
Net Profit	492 492	31% 31% 9%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Encompass Health Corporation Stock News

Neutral

PRNewsWire

●

about 10 hours ago

Encompass Health increases and declares dividend on common stock

BIRMINGHAM, Ala. , July 24, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE:EHC) today announced that its board of directors approved an increase in the Company's quarterly dividend of $0.02 and declared a quarterly cash dividend on its common stock of $0.19 per share, payable on Oct. 15, 2025, to holders of record on Oct. 1, 2025.

Neutral

PRNewsWire

●

one day ago

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Encompass Health Corporation (NYSE: EHC) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

NEWTOWN, Pa. , July 23, 2025 /PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Encompass Health Corporation ("Encompass") (NYSE: EHC), resulting from allegations of providing potentially misleading information to the investing public.

Neutral

PRNewsWire

●

6 days ago

Encompass Health announces plans to build a 40-bed inpatient rehabilitation hospital in Cleveland, Tennessee

BIRMINGHAM, Ala. and CLEVELAND, Tenn.

More Encompass Health Corporation News

Company Profile

Encompass Health Corp. engages in providing post-acute healthcare services. It operates through the following segments: Inpatient Rehabilitation and Home Health & Hospice. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provides rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac & pulmonary conditions, brain & spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.

Head office	United States
CEO	Mark Tarr
Employees	25,191
Founded	1984
Website	www.encompasshealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now